0000899243-21-008619.txt : 20210301
0000899243-21-008619.hdr.sgml : 20210301
20210301161523
ACCESSION NUMBER: 0000899243-21-008619
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210301
DATE AS OF CHANGE: 20210301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chaudhary Kleem
CENTRAL INDEX KEY: 0001817587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39425
FILM NUMBER: 21697915
MAIL ADDRESS:
STREET 1: C/O CHECKMATE PHARMACEUTICALS, INC.
STREET 2: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkmate Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001651431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364813934
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 978-503-2124
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-26
0
0001651431
Checkmate Pharmaceuticals, Inc.
CMPI
0001817587
Chaudhary Kleem
C/O CHECKMATE PHARMACEUTICALS, INC.
245 MAIN STREET, 2ND FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Chief Business Officer
Common Stock
2021-02-26
4
M
0
2000
2.62
A
8000
D
Stock Option (right to buy)
2.62
2021-02-26
4
M
0
2000
0.00
D
2029-11-13
Common Stock
2000
97508
D
25% of the shares subject to such option vested and became exercisable on November 1, 2020 with the remainder to vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Kleem Chaudhary
2021-03-01